000 01532 a2200445 4500
005 20250518055252.0
264 0 _c20200526
008 202005s 0 0 eng d
022 _a1097-0142
024 7 _a10.1002/cncr.32447
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHavrilesky, Laura J
245 0 0 _aPatient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer.
_h[electronic resource]
260 _bCancer
_c12 2019
300 _a4399-4406 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCytoreduction Surgical Procedures
_xadverse effects
650 0 4 _aDecision Making
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aOvarian Neoplasms
_xdiagnosis
650 0 4 _aPatient Preference
650 0 4 _aPrognosis
650 0 4 _aTreatment Outcome
700 1 _aYang, Jui-Chen
700 1 _aLee, Paula S
700 1 _aSecord, Angeles Alvarez
700 1 _aEhrisman, Jessie A
700 1 _aDavidson, Brittany
700 1 _aBerchuck, Andrew
700 1 _aDarcy, Kathleen M
700 1 _aMaxwell, G Larry
700 1 _aReed, Shelby D
773 0 _tCancer
_gvol. 125
_gno. 24
_gp. 4399-4406
856 4 0 _uhttps://doi.org/10.1002/cncr.32447
_zAvailable from publisher's website
999 _c30046509
_d30046509